These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 6142713)

  • 1. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF; Mehta J; Spilberg I
    Biochem Pharmacol; 1984 Feb; 33(3):407-12. PubMed ID: 6142713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
    Gray GD; Ohlmann GM
    Proc Soc Exp Biol Med; 1986 Feb; 181(2):256-62. PubMed ID: 2868456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J; Hoff SF
    Gen Pharmacol; 1989; 20(3):329-34. PubMed ID: 2545509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic peptide binding by intact neutrophils from human neonates.
    Strauss RG; Snyder EL
    Pediatr Res; 1984 Jan; 18(1):63-6. PubMed ID: 6322097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine.
    Hurst NP; French JK; Gorjatschko L; Betts WH
    Ann Rheum Dis; 1987 Oct; 46(10):750-6. PubMed ID: 2825613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H2O2 production while decreasing [3H]FMLP binding.
    Iannone MA; Wolberg G; Reynolds-Vaughn R; Zimmerman TP
    Agents Actions; 1987 Aug; 21(3-4):278-80. PubMed ID: 2891263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils.
    Psychoyos S; Smith CW
    Agents Actions; 1989 Mar; 26(3-4):372-7. PubMed ID: 2735228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
    Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.
    Capsoni F; Ongari AM; Reali E; Bosè F; Altomare GF
    Int J Immunopathol Pharmacol; 2012; 25(3):617-26. PubMed ID: 23058012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Huang YJ; Chen IS; Tseng CP; Day YJ; Lin YC; Liao CH
    Biochem Pharmacol; 2008 Feb; 75(3):688-97. PubMed ID: 17988652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol inhibits fMLP-induced neutrophil migration and superoxide production by upregulating MKP-2 and dephosphorylating ERK.
    Zhang P; Fu Y; Ju J; Wan D; Su H; Wang Z; Rui H; Jin Q; Le Y; Hou R
    Int Immunopharmacol; 2019 Oct; 75():105787. PubMed ID: 31401382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils.
    Brazil TJ; Rossi AG; Haslett C; McGorum B; Dixon PM; Chilvers ER
    J Leukoc Biol; 1998 Mar; 63(3):380-8. PubMed ID: 9500527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP
    J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.